The Complementarity Principle-One More Step towards Analytical Docking on the Example of Dihydrofolate Reductase Complexes.
3D maps of electron density
complementarity
dihydrofolate reductase
docking
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
19 Sep 2021
19 Sep 2021
Historique:
received:
07
09
2021
revised:
14
09
2021
accepted:
16
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
New approaches to assessing the "enzyme-ligand" complementarity, taking into account hydrogens, have been proposed. The approaches are based on the calculation of three-dimensional maps of the electron density of the receptor-ligand complexes. The action of complementarity factors, first proposed in this article, has been demonstrated on complexes of human dihydrofolate reductase (DHFR) with ligands. We found that high complementarity is ensured by the formation of the most effective intermolecular contacts, which are provided due to predominantly paired atomic-atomic interactions, while interactions of the bifurcate and more disoriented type are minimized. An analytical docking algorithm based on the proposed receptor-ligand complementarity factors is proposed.
Identifiants
pubmed: 34575132
pii: life11090983
doi: 10.3390/life11090983
pmc: PMC8469765
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : RFBR and Chelyabinsk Region
ID : 20-415-740008
Références
Semin Oncol. 2003 Jun;30(3 Suppl 6):3-9
pubmed: 12802789
Am J Hum Genet. 2011 Feb 11;88(2):226-31
pubmed: 21310277
J Chem Inf Model. 2021 Apr 26;61(4):1801-1813
pubmed: 33797240
Biochemistry. 2013 Oct 15;52(41):7318-26
pubmed: 24053334
J Comput Aided Mol Des. 2008 Jun-Jul;22(6-7):489-505
pubmed: 18357415
Anticancer Drug Des. 1998 Jun;13(4):307-15
pubmed: 9627670
Bioorg Med Chem. 2011 Jun 1;19(11):3585-94
pubmed: 21550809
Future Med Chem. 2021 May;13(10):863-875
pubmed: 33847171
Br J Cancer. 2004 Jan 26;90(2):526-34
pubmed: 14735204
J Biomol Struct Dyn. 2020 Dec 21;:1-16
pubmed: 33345753
Biochem Pharmacol. 2006 Mar 30;71(7):941-8
pubmed: 16359642
Acta Crystallogr F Struct Biol Commun. 2015 Jun;71(Pt 6):799-803
pubmed: 26057816
Phys Rev B Condens Matter. 1994 May 15;49(19):13348-13356
pubmed: 10010268
Curr Drug Discov Technol. 2019;16(4):437-448
pubmed: 30147011
Acta Crystallogr D Biol Crystallogr. 2002 Jun;58(Pt 6 No 1):899-907
pubmed: 12037327
J Med Chem. 1998 Aug 27;41(18):3426-34
pubmed: 9719595
PLoS One. 2013;8(4):e60470
pubmed: 23577115
J Mol Biol. 2002 Jul 12;320(3):677-93
pubmed: 12096917
J Med Chem. 2009 Aug 13;52(15):4892-902
pubmed: 19719239
Protein Sci. 2018 Jan;27(1):316-330
pubmed: 29067736
Future Med Chem. 2020 Aug;12(15):1387-1397
pubmed: 32689817
Nature. 1953 Apr 25;171(4356):737-8
pubmed: 13054692
Curr Top Med Chem. 2018;18(22):1955-1975
pubmed: 30499394
Cell Rep. 2019 Jun 11;27(11):3359-3370.e7
pubmed: 31189117